|
× |
 |
Hallucinations Following Intravenous Use of Tapentadol PDF |
$40.00 |
|
$40.00 |
|
× |
|
Baseline Cardiovascular Risk Factors in Patients With Severe Mental Illness (SMI) and Second Generation Antipsychotic Use From the Fixed Dose Intervention Trial of New England Enhancing Survival in SMI (FITNESS) PDF |
$40.00 |
|
$40.00 |
|
× |
|
Involuntary Hospitalization of Primary Care Patients PDF |
$40.00 |
|
$40.00 |
|
× |
|
Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Psychological-Behavioral Intervention to Improve Physical Activity in Midlife Adults With Low Baseline Physical Activity PDF |
$40.00 |
|
$40.00 |
|
× |
|
Reversal of Antipsychotic-Associated Weight Gain PDF |
$40.00 |
|
$40.00 |
|
|
